Skip to main navigation Skip to search Skip to main content

Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015

  • L. Galluzzi
  • , J. M. Bravo-San Pedro
  • , I. Vitale
  • , S. A. Aaronson
  • , J. M. Abrams
  • , D. Adam
  • , E. S. Alnemri
  • , L. Altucci
  • , D. Andrews
  • , M. Annicchiarico-Petruzzelli
  • , E. H. Baehrecke
  • , N. G. Bazan
  • , M. J. Bertrand
  • , K. Bianchi
  • , M. V. Blagosklonny
  • , K. Blomgren
  • , C. Borner
  • , D. E. Bredesen
  • , C. Brenner
  • , M. Campanella
  • E. Candi, F. Cecconi, F. K. Chan, N. S. Chandel, E. H. Cheng, J. E. Chipuk, J. A. Cidlowski, A. Ciechanover, T. M. Dawson, V. L. Dawson, V. De Laurenzi, R. De Maria, K. M. Debatin, N. Di Daniele, V. M. Dixit, B. D. Dynlacht, W. S. El-Deiry, G. M. Fimia, R. A. Flavell, S. Fulda, C. Garrido, M. L. Gougeon, D. R. Green, H. Gronemeyer, G. Hajnoczky, J. M. Hardwick, M. O. Hengartner, H. Ichijo, B. Joseph, P. J. Jost, T. Kaufmann, O. Kepp, D. J. Klionsky, R. A. Knight, S. Kumar, J. J. Lemasters, B. Levine, A. Linkermann, S. A. Lipton, R. A. Lockshin, C. López-Otín, E. Lugli, F. Madeo, W. Malorni, J. C. Marine, S. J. Martin, J. C. Martinou, J. P. Medema, P. Meier, S. Melino, N. Mizushima, U. Moll, C. Muñoz-Pinedo, G. Nuñez, A. Oberst, T. Panaretakis, J. M. Penninger, M. E. Peter, M. Piacentini, P. Pinton, J. H. Prehn, H. Puthalakath, G. A. Rabinovich, K. S. Ravichandran, R. Rizzuto, C. M. Rodrigues, D. C. Rubinsztein, T. Rudel, Y. Shi, H. U. Simon, B. R. Stockwell, G. Szabadkai, S. W. Tait, H. L. Tang, N. Tavernarakis, Y. Tsujimoto, T. Vanden Berghe, P. Vandenabeele, A. Villunger, E. F. Wagner, H. Walczak, E. White, W. G. Wood, J. Yuan, Z. Zakeri, B. Zhivotovsky, G. Melino, G. Kroemer
  • University of Paris Sud
  • Centre de Recherche des Cordeliers
  • Université Paris Cité
  • Institut national de la santé et de la recherche médicale
  • IRCCS Istituti fisioterapici ospitalieri - Istituto Regina Elena
  • Icahn School of Medicine at Mount Sinai
  • University of Texas Southwestern Medical Center
  • Kiel University
  • Thomas Jefferson University
  • University of Campania Luigi Vanvitelli
  • University of Toronto
  • IRCCS Istituto Dermopatico dell'Immacolata - Roma
  • University of Massachusetts Medical School
  • Louisiana State University Health Sciences Center
  • Flanders Institute for Biotechnology
  • Ghent University
  • Cancer Research UK
  • Queen Mary University of London
  • Roswell Park Cancer Institute
  • Karolinska Institutet
  • University of Freiburg
  • Buck Institute for Age Research
  • University of California at San Francisco
  • LabEx LERMIT
  • Université Paris-Saclay
  • University College London
  • University of Rome Tor Vergata
  • IRCCS Fondazione Santa Lucia - Roma
  • Danish Cancer Society
  • Northwestern University
  • Memorial Sloan-Kettering Cancer Center
  • National Institutes of Health
  • Technion-Israel Institute of Technology
  • Johns Hopkins University
  • Adrienne Helis Malvin Medical Research Foundation
  • Gabriele d'Annunzio University
  • Ulm University
  • Genentech, Inc
  • New York University
  • Pennsylvania State University
  • University of Salento
  • IRCCS Istituto per le Malattie Infettive Lazzaro Spallanzani - Roma
  • Yale University
  • Goethe University Frankfurt
  • INSERM U1231 'Lipides Nutrition Cancer'
  • Université de Bourgogne
  • Institut Pasteur Paris
  • St. Jude Children Research Hospital
  • Institute of Genetics and Molecular and Cellular Biology (IGBMC)
  • University of Zurich
  • The University of Tokyo
  • Technical University of Munich
  • University of Bern
  • University of Michigan, Ann Arbor
  • University of Cambridge
  • Centre for Cancer Biology
  • Adelaide University
  • Medical University of South Carolina
  • University of Texas at Dallas
  • Howard Hughes Medical Institute
  • Scripps Research Institute
  • and Stem Cell Research
  • Salk Institute for Biological Studies
  • University of California at San Diego
  • St. John's University
  • University of Oviedo
  • IRCCS Istituto Clinico Humanitas - Rozzano (Milano)
  • University of Graz
  • Istituto Superiore di Sanita
  • San Raffaele Institute
  • KU Leuven
  • Trinity College Dublin
  • University of Geneva
  • Academic Medical Center
  • The Institute of Cancer Research
  • Bellvitge Biomedical Research Institute
  • University of Washington
  • Austrian Academy of Sciences
  • University of Ferrara
  • Royal College of Surgeons in Ireland
  • La Trobe University
  • Consejo Nacional de Investigaciones Científicas y Técnicas
  • University of Virginia
  • University of Padua
  • University of Lisbon
  • University of Würzburg
  • Soochow University
  • Columbia University
  • Beatson Institute for Cancer Research
  • University of Glasgow
  • Foundation for Research and Technology-Hellas
  • University of Crete
  • Osaka International Cancer Institute
  • Innsbruck Medical University
  • Spanish National Cancer Research Centre (CNIO)
  • Rutgers - The State University of New Jersey, New Brunswick
  • University of Minnesota Twin Cities
  • Department of Veterans Affairs
  • Harvard University
  • City University of New York
  • Lomonosov Moscow State University
  • Labex Immuno-Oncology

Research output: Contribution to journalReview articlepeer-review

881 Scopus citations

Abstract

Cells exposed to extreme physicochemical or mechanical stimuli die in an uncontrollable manner, as a result of their immediate structural breakdown. Such an unavoidable variant of cellular demise is generally referred to as 'accidental cell death' (ACD). In most settings, however, cell death is initiated by a genetically encoded apparatus, correlating with the fact that its course can be altered by pharmacologic or genetic interventions. 'Regulated cell death' (RCD) can occur as part of physiologic programs or can be activated once adaptive responses to perturbations of the extracellular or intracellular microenvironment fail. The biochemical phenomena that accompany RCD may be harnessed to classify it into a few subtypes, which often (but not always) exhibit stereotyped morphologic features. Nonetheless, efficiently inhibiting the processes that are commonly thought to cause RCD, such as the activation of executioner caspases in the course of apoptosis, does not exert true cytoprotective effects in the mammalian system, but simply alters the kinetics of cellular demise as it shifts its morphologic and biochemical correlates. Conversely, bona fide cytoprotection can be achieved by inhibiting the transduction of lethal signals in the early phases of the process, when adaptive responses are still operational. Thus, the mechanisms that truly execute RCD may be less understood, less inhibitable and perhaps more homogeneous than previously thought. Here, the Nomenclature Committee on Cell Death formulates a set of recommendations to help scientists and researchers to discriminate between essential and accessory aspects of cell death.

Original languageEnglish
Pages (from-to)58-73
Number of pages16
JournalCell Death and Differentiation
Volume22
Issue number1
DOIs
StatePublished - Jan 1 2015

Fingerprint

Dive into the research topics of 'Essential versus accessory aspects of cell death: Recommendations of the NCCD 2015'. Together they form a unique fingerprint.

Cite this